Endonovo Therapeutics Overview

Life ScienceCompany

Was Endonovo Therapeutics formerly PE-backed?

Yes. Endonovo Therapeutics was formerly owned by 1 private investor.

Where is Endonovo Therapeutics headquartered?

Endonovo Therapeutics is headquartered in Woodland Hills, California.

What sector is Endonovo Therapeutics in?

Endonovo Therapeutics is a life science company.

When was Endonovo Therapeutics founded?

Endonovo Therapeutics was founded in 2008.

Endonovo Therapeutics

Endonovo Therapeutics, Inc.

6320 Canoga Avenue, 15th Floor,
Woodland Hills, California 91367
United States,
(800) 489-4774
www.endonovo.com

Endonovo Therapeutics is a biotechnology company developing off-the-shelf, cell-free regenerative products and non-invasive, bioelectronic therapies designed to extend and enhance human life by regenerating tissues and organs that have become injured or damaged due to disease and age. Endonovo Therapeutics was founded in 2008 and is headquartered in Woodland Hills, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - 1 - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.